ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

11.85
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Enzymotec Ltd. - Ordinary Shares (delisted) NASDAQ:ENZY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.85 0.05 199,999.95 0 01:00:00

Report of Foreign Issuer (6-k)

17/05/2017 12:59pm

Edgar (US Regulatory)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
For the month of May 2017
 
Commission File Number: 001-36073
 
                   ENZYMOTEC LTD.                     
(Translation of registrant’s name into English)
 
Sagi 2000 Industrial Area
P.O. Box 6
 Migdal Ha’Emeq 2310001, Israel

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F ☒          Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __
 

CONTENTS
 
On May 17, 2017, Enzymotec Ltd. (NASDAQ: ENZY) (the “ Company ”) announced its financial results for the first quarter ended March 31, 2017.  A copy of the press release announcing the Company’s results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (“ Form 6-K ”) and is incorporated herein by reference.
  
The information in this Form 6-K, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing.
 

  
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      
EYZMOTEC LTD.
   
Dated: May 17, 2017
By: /s/ Oren Bryan
 
Name: Oren Bryan
 
Title:  Chief Financial Officer
 

 
EXHIBIT INDEX
 
The following exhibit is furnished as part of this Form 6-K:
 
Exhibit
 
Description
 99.1
 
Press release dated May 17, 2017

 


1 Year ENZYMOTEC LTD. Chart

1 Year ENZYMOTEC LTD. Chart

1 Month ENZYMOTEC LTD. Chart

1 Month ENZYMOTEC LTD. Chart